Milestone Pharmaceuticals (MIST) Debt Ratio (2023 - 2026)

Milestone Pharmaceuticals (MIST) has reported Debt Ratio for 4 consecutive years, with 0.33 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Debt Ratio fell 72.02% year-over-year to 0.33; the trailing twelve-month figure through Jun 2026 stood at 0.33 (down 72.02% YoY), and the FY2025 full-year result was 0.5, down 28.73% from the prior year.
• Debt Ratio improved to 0.33 in Q2 2026 per MIST's latest filing, from 0.3 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.16 in Q2 2025 and bottomed at 0.3 in Q1 2026.
• Historically, Debt Ratio has averaged 0.6 across 4 years, with a median of 0.57 in 2024.
• The sharpest annual moves came in 2025 and 2026: Debt Ratio jumped 101.72% in 2025, then plunged 72.02% in 2026.
• Over 4 years, Debt Ratio stood at 0.66 in 2023, then advanced by 6.81% to 0.71 in 2024, then fell by 28.73% to 0.5 in 2025, then slumped by 35.27% to 0.33 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.33, 0.3, and 0.5 for Q2 2026, Q1 2026, and Q4 2025 respectively.